Frontiers in Aging · Nov 17, 2026

Impact of Aging on Immunometabolism in Women and the Nexus with Vascular Health: a Narrative Review

By Elena Ciaglia, Iqra Elahi, Valentina Lopardo et al.

Cardiovascular disease is the leading cause of morbidity and mortality in postmenopausal women, whose vascular risk increases sharply following the menopausal transition with accelerated arterial stiffening, endothelial dysfunction, and increased oxidative stress implicated in vascular aging. Despite this clinical urgency, women remain underrepresented in mechanistic aging research, leaving important gaps in the understanding of sex-specific cardiovascular pathophysiology. Emerging evidence points to immunometabolism — the reciprocal interplay between immune cell function and metabolic regulation — as a useful organizing framework for understanding vascular aging in this population. Estrogen withdrawal and age-related metabolic changes, including visceral adiposity, may contribute to reduced immune-cell metabolic flexibility and pro-inflammatory phenotypes, potentially promoting chronic low-grade inflammation that may impair endothelial function through reduced nitric oxide bioavailability, increased reactive oxygen species production, and promotion of endothelial senescence. The vascular endothelium, functioning as an immune-responsive organ, integrates these signals through cytokine-mediated pathways and immune cell potentially reinforcing vascular inflammation. Sex-specific differences in immune aging — including estrogen associated macrophage polarization, altered IgG glycosylation patterns, and distinct endothelial transcriptional profiles — suggest that the regulation and relative contributions of pathways involved in cardiovascular aging may differ between women and men, although direct comparative evidence remains limited. This review adopts an integrated, sex-specific immunometabolic perspective to examine the molecular and cellular underpinnings of vascular aging in postmenopausal women, addressing a field with important evidence gaps and potential translational implications for cardiovascular prevention and therapy. Evidence from human studies is distinct from findings in experimental models, and further longitudinal research is needed to establish causal relationships.

The paperJournal siteMechanisms

AgingResearch.News